Blood cancers

Modified chemo regimen less toxic for transplant-ineligible lymphoma patients

A pared back three-drug salvage regimen for patients with relapsed-refractory diffuse large B-cell lymphoma (RR-DLBCL) who are ineligible for stem cell transplant provides outcomes ‘as good’ as a widely used four-drug regimen but with the benefit of reduced toxicity, according to an Australian study. Investigators from NSW, Victoria and Canberra who conducted the multicentre phase ...

Already a member?

Login to keep reading.

© 2021 the limbic